Full-Time

Director or Senior Director of IT Infrastructure and Operations

Confirmed live in the last 24 hours

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops targeted protein degradation therapies

Biotechnology
Healthcare

Senior, Expert

Belmont, MA, USA

US Citizenship Required

Category
DevOps & Infrastructure
Cloud Engineering
DevOps Engineering
Required Skills
AWS
Development Operations (DevOps)
Requirements
  • A minimum of 10 years of Information Technology experience, with at least 6 years in IT management roles.
  • Extensive experience with Amazon Web Services (AWS), including designing, deploying, and managing AWS infrastructure and services.
  • AWS certifications (e.g., AWS Certified Solutions Architect, AWS Certified SysOps Administrator) are highly desirable.
  • Demonstrated ability to manage diverse projects simultaneously, requiring detailed analysis, creative problem-solving, time management, and sound judgment.
  • Strong vendor management experience, including contract negotiation, vendor selection, and performance management.
  • Experience supporting an environment with 200+ end users.
  • Experience in small company or start-up environments within the life sciences or biotechnology industry is preferred.
  • Experience in computer operations, network management, technical management, and end-user support.
  • Familiarity with ITIL processes and experience implementing and/or managing IT incident/service request management, IT configuration management, and computer system validation.
  • Experience with SaaS and hosted applications, including Okta, Office 365, and other cloud services.
  • Ability to work effectively in a small, fast-paced IT team, demonstrating strong communication and interpersonal skills.
  • Proven budget management experience.
  • Ability to manage multiple projects, activities, and tasks simultaneously, prioritizing effectively to meet deadlines.
Responsibilities
  • Lead the day-to-day operations of Kymera’s network, storage, security, and AWS cloud infrastructure.
  • Develop and execute a cloud strategy leveraging AWS services to meet business objectives, including scalability, reliability, and cost-effectiveness.
  • Oversee the deployment, monitoring, maintenance, development, upgrade, and support of security systems, servers, desktop devices, IT operations applications, networks, and the service desk.
  • Implement best practices for AWS architecture, including security, compliance, high availability, and disaster recovery.
  • Manage system configurations, software installations, updates, and upgrades to Windows servers, AWS services, applications, and other infrastructure systems.
  • Monitor system performance and availability, proactively taking steps to maximize uptime and performance across both cloud and on-premises environments.
  • Manage and mature the IT service desk, ensuring mutually defined SLAs are achieved and continuously improved.
  • Develop and maintain strong vendor relationships, including contract negotiation, performance management, and ensuring vendors meet agreed-upon service levels.
  • Develop capacity plans and budgets that meet the growth, scalability, and changing needs of the business, optimizing costs across cloud and on-premises infrastructure.
  • Maintain a high level of infrastructure uptime in a fast-paced environment, leveraging automation and DevOps practices where appropriate.
  • Develop and test comprehensive disaster recovery and business continuity plans, particularly in cloud environments.
  • Develop, implement, and maintain IT policies, procedures, and associated plans for security, data center, desktops, and infrastructure based on industry-standard best practices, SOX, FDA, and GxP requirements.
  • Provide leadership and mentorship to the End User Services team, fostering professional growth and knowledge sharing.
  • Collaborate with cross-functional teams to understand and meet their IT infrastructure needs, particularly in support of biotechnology research and development activities.

Kymera Therapeutics develops treatments by targeting and breaking down specific proteins that contribute to diseases, particularly cancer and immune disorders. Their main technology, the Pegasus Platform, enables them to identify these harmful proteins and create drug candidates aimed at effectively treating various conditions. Unlike many competitors, Kymera focuses on targeted protein degradation, which can lead to more precise therapies. The company's goal is to create next-generation medicines that address unmet medical needs, supported by partnerships with organizations like Sanofi to enhance their research and development efforts.

Company Stage

IPO

Total Funding

$191.6M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

16%
Simplify Jobs

Simplify's Take

What believers are saying

  • Kymera's recent $275 million public offering provides substantial capital to advance their clinical programs and expand their pipeline.
  • The FDA Fast Track designation for KT-333 could accelerate its development and bring it to market faster, benefiting patients with relapsed/refractory lymphomas.
  • Positive data from ongoing cancer drug trials and the unveiling of KT-294 highlight Kymera's potential for significant breakthroughs in oncology and immunology.

What critics are saying

  • The high costs and long timelines associated with biopharmaceutical R&D could strain Kymera's financial resources despite recent funding.
  • Dependence on partnerships, such as with Sanofi, introduces risks related to collaboration dynamics and milestone achievements.

What makes Kymera Therapeutics unique

  • Kymera Therapeutics leverages its proprietary Pegasus Platform for targeted protein degradation, setting it apart from traditional drug development approaches.
  • Their strategic partnership with Sanofi underscores their credibility and enhances their research capabilities, unlike smaller biotech firms with limited collaborations.
  • Kymera's focus on developing first-in-class therapies for cancer and immune disorders positions them uniquely in the biopharmaceutical market.

Help us improve and share your feedback! Did you find this helpful?